PDA

View Full Version : General Cancer News


Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 [22] 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51

  1. U-Systems somo•v Automated Breast Ultrasound system granted FDA PMA approvable letter
  2. BI-RADS useful in predicting malignant breast lesions detected with MRI
  3. Cyclophosphamide drug makes the bone marrow more tumor-friendly
  4. Combination of vaccine and letrozole effectively improves survival from breast cancer
  5. CINJ prefers more personalized approach to prescribing cancer treatment
  6. Lecture discusses how negative emotions fuel cancer formation and metastasis
  7. Results from Boehringer Ingelheim’s LUX-Lung 3 Phase III trial on stage IIIB or IV NS
  8. Combination of daclizumab and vaccine improves survival of breast cancer patients
  9. NanoString commences second clinical study of PAM50-based breast cancer assay
  10. Project aims to find new diagnostic tools, drugs for triple negative breast cancer
  11. TJU researchers to investigate Cu-64 imaging agent for prostate cancer
  12. Apigenin effective against human breast cancer
  13. Breast cancer cell surface protein blows cover of potent tumor-generating cells
  14. Researchers sequence genomes of 21 breast cancers
  15. Study: No racial and ethnic disparities in preoperative breast cancer imaging
  16. Conservative group makes major ad buy to charge President Obama with using the health
  17. Breast cancer vaccine that elicits powerful immune response also improves recurrence
  18. Promising updates in quest for early detection and treatments for lung cancer
  19. Panobinostat able to target and destroy triple negative breast cancer
  20. HS6ST2 enzyme an important regulator of breast cancer cell-bone interactions
  21. Study shows how a drug-lead compound suppresses tumour formation
  22. Biomarker neutralizes effect of bevacizumab in pancreas and kidney cancer patients
  23. Deletion of 'lunatic fringe' promotes tumor formation of basal-like breast cancers
  24. HSF-1 protein likely source of chemotherapy-related heart damage in mice
  25. MRI provides early indication of breast tumor's response to pre-surgical chemotherapy
  26. Special feature of Science journal highlights protein array technology
  27. MCP enhances anti-cancer effects of two poly-botanical formulas
  28. New clinical trial to evaluate HSP90 inhibitor plus hormonal therapy for breast cance
  29. MTI develops SureTouch Wireless system for breast cancer screening
  30. Viewpoints: The promise and perils of prostate screening; Presidential candidates shy
  31. Preliminary results from Celldex’s CDX-011 Phase 2b breast cancer study
  32. Halo Healthcare acquires assets of NeoMatrix
  33. Poor cardio-pulmonary function may be strong predictor of survival in women with brea
  34. Researchers identify single gene that controls aging, inflammation and cancer
  35. Study says most insurance sold to individuals doesn't meet health law standards
  36. Thioridazine drug successfully kills human cancer stem cells
  37. Blocking Skp2 protein might inhibit glycolysis and treat breast cancer
  38. Increased risk of breast cancer associated with working night shifts
  39. Safety of breast implants
  40. Studies outline dilemmas on new generic heart drugs, hormone replacement therapy
  41. Overdiagnosis: harming the healthy
  42. Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC
  43. Pfizer’s XALKORI now available in Canada
  44. TAU researcher develops new antibodies to target and destroy cancer cells
  45. GE to provide attendees with overview of new oncology solutions at ASCO annual meetin
  46. Simple blood test can detect genetic faults in patients with cancer
  47. Researchers develop special brassiere for breast cancer patients
  48. Kindstar, Insight Genetics collaborate to improve cancer care in China
  49. Scientists succeed in solving first structure of a Wnt protein
  50. Personalized medicine and the Human Genome Project
  51. Researchers discover binding partner of TDF hormone
  52. Montefiore experts available to discuss cancer research at 2012 ASCO meeting
  53. America's biopharmaceutical researchers work on many new approaches to fight cancer
  54. Agendia launches ColoPrint microarray-based 18-gene expression signature for colon ca
  55. 'Atzelberg Circle' researchers meet to advance hyperthermia as standard combination c
  56. UH CNRCS students achieve significant milestones in cancer therapy research
  57. Studies support diagnostic utility of molecular classification in difficult-to-diagno
  58. Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory
  59. Study reveals why GBM is highly resistant to current chemotherapies
  60. Avastin (bevacizumab)-induced tumor calcifications can be elicited in glioblastoma
  61. Roche to initiate three studies with T-DM1 for early stage HER2-positive breast cance
  62. Affibody, GE Healthcare partner to develop Her2-targeted PET imaging agent
  63. Genentech’s T-DM1 Phase III study on HER2-positive mBC meets primary endpoint
  64. Variation in microRNAs may explain survival differences in breast cancer
  65. Data from several clinical trials of ADCETRIS to be presented at ASCO annual meeting
  66. Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer
  67. Results from Puma’s PB272 Phase I combination trial on metastatic HER-2 positive brea
  68. ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast
  69. New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors
  70. Androgen receptor an additional hormonal target in many breast cancers
  71. Caffeine/coffee intake associated with reduced risk of dementia or delayed onset
  72. Researchers uncover cellular basis for age-related breast cancer vulnerability
  73. Alnylam announces results from ALN-VSP Phase I study on liver cancers
  74. High doses of ginseng more effectively reduce cancer-related fatigue in patients
  75. Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancrea
  76. Preoperative breast cancer pain involves an inflammatory process
  77. Study detects significant changes in the EEG brain activity patterns during chemother
  78. T-DM1 better than standard therapy in controlling breast cancer
  79. New immune response data from Generex’s AE37 Phase II trial on breast cancer
  80. bioTheranostics’ CancerTYPE ID molecular test improves overall survival for patients
  81. Cardio-protective drug during cancer treatment may prevent heart damage in children
  82. Better diagnosis of breast cancer could come from simple blood test
  83. Work pattern affects night shift–breast cancer link
  84. CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing
  85. Debiopharm announces results from Debio 0932 Phase I study on cancer
  86. New data supports clinical role of Cambridge Heart’s MTWA test in managing patients a
  87. Genentech receives FDA approval for Perjeta to treat HER2-positive metastatic breast
  88. ADAM28 inhibits VWF-mediated cancer cell apoptosis and enhances lung metastases
  89. BioSante to initiate two new LibiGel Phase III efficacy trials in FSD, HSDD
  90. Distinct cancer 'signatures' may help predict response to estrogen-lowering therapy
  91. Investigational drug slows metastatic breast cancer progression
  92. ColoPrint aids prediction of colorectal cancer relapse
  93. Premature cancer death risk may be increased by dental plaque
  94. Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective
  95. Unnecessary medical imaging can reduce risk of breast cancer in women
  96. Study investigates how breast cancer cells migrate to bone
  97. Study reveals molecular link between aging and cancer
  98. Variations in microRNA expression within breast tumors can lead to sampling bias
  99. CINJ commences enrollment in three-drug combination trial for breast cancer
  100. In Calif. and Mass., reforms proceeding even as court causes uncertainty
  101. Bisphosphonate benefit for breast cancer yet to be proven
  102. Inserm researchers examine effect of night work on women’s health
  103. Value of pathology review highlighted in node-negative breast cancer
  104. New robotic device can improve detection of breast cancer
  105. Review describes new classes of drugs that target androgens in novel ways
  106. GBM patients with CNP subtype may have less aggressive subtype of cancer
  107. Novel small-molecule-inhibiting drug stops spread of breast cancer cells
  108. FDA advisory panel issues positive opinion for Dune's MarginProbe System
  109. Genentech's Perjeta helps people with HER2-positive metastatic breast cancer live lon
  110. New paper discusses potential of tumor-derived microvesicles
  111. Deferasirox reduces elevated iron levels in patients with myelodysplastic syndrome
  112. Physical activity linked with reduced risk of breast cancer
  113. Amgen launches Chemotherapy: Myths or Facts campaign for cancer patients
  114. LLUMC suggests check list with six key attributes for successful proton therapy treat
  115. p53 protein may show a typical prion-like behavior when mutated
  116. Cancer survivors benefit from healthy lifestyle
  117. Experimental medication increases muscle strength in cancer patients with low testost
  118. Metformin reduces overall cancer risk in patients with Type 2 diabetes
  119. Report on the global market for breast cancer diagnostics and drug technologies
  120. Sunshine Biopharma completes Adva-27a cytotoxicity study on multidrug-resistant lung
  121. Top-line final data from Provectus’ PV-10 phase 2 trial on metastatic melanoma
  122. Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulth
  123. GUMC receives NIH grant to establish Center of Excellence for Health Disparities
  124. Decline in preventive mammography rates after USPSTF recommendation
  125. ‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed
  126. ‘Risky’ view of thrombolysis in subtherapeutic warfarin patients disputed
  127. Study examines role and biological effects of psychotherapy in breast cancer survivor
  128. ACR updates 39 appropriateness criteria topics and adds five new criteria
  129. Flexible wearable antenna system for breast tumor detection
  130. Shorter regimen of radiotherapy safe for noninvasive breast cancer patients
  131. Clinical results for Teva's biologic oncology candidates presented at MASCC/ISOO 2012
  132. Shots to the heart ‘not risky’
  133. Study demonstrates effectiveness of combination therapy for breast cancer cells in vi
  134. Imaging PR status may help identify tumor response to endocrine therapy
  135. GRP78 play an important role in breast cancers that respond to anti-estrogen therapy
  136. PGD for breast cancer genes BRCA1/2 is now feasible
  137. NOTCH1 signaling promotes T-cell acute lymphoblastic leukemia-initiating cell regener
  138. 23andMe identifies seven SNPs associated with breast size
  139. Former President Bush in Zambia, Botswana to promote Pink Ribbon Red Ribbon initiativ
  140. Italy's first successful pregnancy and delivery following transplantation of ovarian
  141. Single dose breast cancer treatment helps forego 6-7 week radiation regimen
  142. Scientists identify causative link between oncometabolite and onset of AML
  143. Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin
  144. The Center for Cancer Support and Education in Arlington to receive $10,000 ASTRO gra
  145. Insight into understanding IDH mediated disease
  146. NewYork-Presbyterian/WCMC first in N.Y. City to offer INTRABEAM radiotherapy
  147. New optical microscope identifies rare breast cancer cells
  148. Study determines risk of young-onset breast cancer after use of ovulation-stimulating
  149. Hormone therapy still an acceptable treatment for menopausal symptoms: New joint stat
  150. Protein interactions outside breast cancer cells can permanently stop proliferation
  151. MammaPrint more cost-effective and clinically-useful test than Oncotype DX
  152. RA patients do not receive fewer cancer screening tests than general population: Stud
  153. Scientists develop novel anticancer drug designed to travel through the bloodstream
  154. Biomarkers predict benefit of targeted therapy in metastatic renal-cell cancer
  155. Book explains complex world of personalized medicine
  156. New approach integrates rational drug design with supramolecular nanochemistry in can
  157. Breast cancer dug bevacizumab slows progression but has no overall survival benefit
  158. Prenatal and early childhood exposure to PCE may be associated with long-term visual
  159. New assay can identify rare cancerous cells within mixed populations
  160. Low-fat, high fruit and vegetable diet may help reduce menopausal symptoms
  161. Nutrisystem announces debut of enhanced weight management plan for people with diabet
  162. Breast cancer patients who undergo breast conserving surgery often have a reoperation
  163. Patient interaction with medical record boosts prevention service use
  164. Rheumatoid arthritis patients take-up cancer screening
  165. Ampio announces advancement of NCE001 to preclinical development
  166. Lack of physical activity causes 1 in 10 deaths
  167. New roadmap provides expert guidance on how to reduce racial and ethnic health dispar
  168. Cancer more likely in people with serious mental illnesses
  169. People with schizophrenia more likely to develop cancer
  170. Researchers discover potential drug targets that might reduce ventilator-induced lung
  171. HAS-BLED: Atrial fibrillation patients undergoing angioplasty can still take anticoag
  172. Ablation technique destroys eye of the storm
  173. A world of consequences due to physical inactivity
  174. Unsuccessful fertility treatment reduces young-onset breast cancer risk
  175. Breast-conserving surgery carries high reoperation risk
  176. Novartis receives FDA approval for Afinitor to treat HER2-negative breast cancer
  177. Researchers discover reason why breast cancer cells become drug resistant
  178. International Congress on Natural Products Research to be held in New York City
  179. First Edition: July 23, 2012
  180. AF deaths more likely on the weekend
  181. Fat grafts ‘safe’ following breast reconstruction
  182. SUMEC to distribute Aurora's breast MRI technology in China
  183. Berg Pharma initiates BPM 31543 clinical trial for chemotherapy-induced alopecia
  184. HALO, UND enter agreement to develop biomarkers for early detection of breast cancer
  185. Queen's University, Cirdan Imaging partner to develop novel techniques for cancer det
  186. RhoC gene promotes breast cancer stem cell progression
  187. Daily Beast profiles George W. Bush's post-presidency global health work
  188. EntreMed commences ENMD-2076 Phase 2 study in triple-negative breast cancer
  189. Constant pain after breast cancer surgery ‘more taxing’
  190. Navidea announces results from Lymphoseek Phase 3 trial on head and neck squamous cel
  191. Study investigates molecular markers in drug-resistant ovarian cancer
  192. Lack of physical activity and life expectancy: an interview with Dr I-Min Lee
  193. Study sheds light on complexities of cancer genetics
  194. EPHA3 mutations may be important drivers of lung cancers
  195. TAU researcher reveals link between plant and human biology
  196. Researchers use computational analysis to identify new Achilles heel for drug-resista
  197. Rye Radiology offers new 3D mammography that detects many breast cancers
  198. Scientists discover novel therapeutic target for advanced breast cancer
  199. Researchers discover new approach to treat two lethal metastatic cancers
  200. Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner
  201. First Edition: August 1, 2012
  202. APA Convention to highlight new research in personality and social psychology
  203. MLK3 protein critical driver of breast cancer cell migration and invasion
  204. High maternal choline intake may reduce risk of hypertension and diabetes in babies
  205. In rare compromise, Hill leaders agree on temporary spending deal to keep government
  206. Combination of anastrozole and fulvestrant extends survival in women with metastatic
  207. Study looks at hope experience of male spouses of breast cancer patients
  208. Combination hormonal therapy improves survival in advanced breast cancer
  209. Combination of sitagliptin and lansoprazole offers clinical benefits for T1D patients
  210. Mammography oversold by breast cancer charity
  211. HSF1 increases expression of chaperones and supports cancer metastasis
  212. Sta Op Tegen Kanker International Translational Cancer Research Grant recipients anno
  213. Komen ads overstate benefits of mammograms, professors charge
  214. New sequencing approach can provide more effective method of BRCA1/2 mutational analy
  215. Montefiore launches first fellowship program in Women's Physical Medicine and Rehabil
  216. Human-derived breast cancer xenografts allow revolution in individualized cancer care
  217. ‘Chicken Wing’ clue to stroke risk in atrial fibrillation
  218. Clinical trial targets breast cancer cells by injecting trastuzumab directly into the
  219. New class of drugs reduces adverse effects of cellular damage from cancer chemotherap
  220. New research hopes to uncover mystery behind breast cancer metastasis
  221. Clovis Oncology reports net loss of $15.7 million for second quarter 2012
  222. GTx reports revenue of $1.6 million for second quarter 2012
  223. Old cardiac drug performs new tricks
  224. Inaugural event of National Women's Survivors Convention to be held in Nashville
  225. MedPage Today, CollabRx sign license agreement for Oncology Next
  226. Herceptin® could potentially be delivered via a standard injection
  227. Female voters are hot commodity for presidential candidates
  228. Combination therapy delays progression for metastatic breast cancer patients
  229. Fat transfers may benefit patients after breast reconstructive surgery
  230. Highlights: New reports of problems at Parkland Hospital in Dallas; Mammogram rates d
  231. Radiation after lumpectomy helps prevent need for subsequent mastectomy in older wome
  232. Radiation therapy following lumpectomy may benefit older, early-stage breast cancer p
  233. State roundup: Fla. groups ask Gov. for essential benefits hearings
  234. Springer to publish book series in cooperation with The Breast Cancer Research Founda
  235. Novel method identifies new oncogene that contributes to development of cancer
  236. HAS-BLED proves predictive ability
  237. Early stage breast cancer in older women: an interview with Dr. Benjamin Smith
  238. Viewpoints: Romney needs to explain his Medicare plan; Ryan plan would end Medicaid p
  239. Malignant mesothelioma diagnosis with an E-nose: an interview with Associate Professo
  240. Radiosensitivity molecular signature can lead to better radiation therapy decisions f
  241. Pregnant women who undergo chemotherapy do not appear to increase their baby’s risk o
  242. Research examines racial and ethnic differences in strokes
  243. Peptide combinations might offer more effective cancer therapy
  244. Study examines whether eribulin offers added benefit to women with breast cancer
  245. Anti-cancer regimens with multiple modes of action increase treatment effectiveness
  246. Lack of certain gene occurs in almost 28% of breast cancers
  247. Viewpoints: Insuring medical treatments are well researched; GOP Govs reluctance on e
  248. Mayo Clinic receives approval for construction of new building on Phoenix campus
  249. Higher mammographic density not linked to reduced survival in breast cancer patients
  250. First Edition: August 21, 2012